PRACSNS – Breakthrough Innovation
Provisional Patents Filed.
Clinical trial pending.
A normal patient goes through a complicated, infection prone Dialysis procedure, at a hospital or specialized clinic, three times a week for 4 hours per treatment. Blood, toxins, and fluids are cleansed/removed using an external machine.
Failure to provide a infection free environment can be fatal to patients.
Patients on dialysis experience weakness and various health issues over time.
Over 8 years, our research has shown there is currently no other alternative to Dialysis except Transplant.
PRACSNS has come out with an innovative concept – Catalytic Biodegradable Microbots that need clinical validation and we are setting up our Clinical Advisory Board to reach pig/porcine trials in 9 months, and subsequently human trial in 30 months.
Oral Treatment. No Dialysis machine required. No surgery required. Toxins and fluids removed cleanly.
Benchtop results meet ISO 10993-4 and ASTM F756.
This breakthrough is subject to Clinical trials, validation, and regulatory approvals.
